Acinetobacter baumannii and A. pittii clinical isolates lack adherence and cytotoxicity to lung epithelial cells in vitro

Microbes and Infection

Volumn 18, Issue 9, 2016, Pages 559-564

  Lázaro Díez, María ^a,b   Navascués Lejarza, Teresa ^a   Remuzgo Martínez, Sara ^a   Navas, Jesús ^c   Icardo, José Manuel ^c   Acosta, Felix ^d   Martínez Martínez, Luis ^a,b,c,e   Ramos Vivas, José ^a,b,e  

^a IFIMAV   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Acinetobacter baumannii; Acinetobacter pittii; Adherence; Cytotoxicity; Epithelial cells

Indexed keywords

A549 CELL LINE; ACINETOBACTER BAUMANNII; ACINETOBACTER PITTII; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; CELL INVASION; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; INTERNALIZATION; LUNG ALVEOLUS EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SERRATIA LIQUEFACIENS; TRANSMISSION ELECTRON MICROSCOPY; A-549 CELL LINE; ACINETOBACTER; ACINETOBACTER INFECTION; BACTERIAL PNEUMONIA; CELL SURVIVAL; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHYSIOLOGY;

A549 CELLS; ACINETOBACTER; ACINETOBACTER INFECTIONS; BACTERIAL ADHESION; CELL SURVIVAL; EPITHELIAL CELLS; HUMANS; PNEUMONIA, BACTERIAL;

EID: 84973902475     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2016.05.002     Document Type: Article

References (17)

1. [1] Howard, A., O'Donoghue, M., Feeney, A., Sleator, R.D., Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence 3 (2012), 243–250.
2. [2] Roca, I., Espinal, P., Vila-Farres, X., Vila, J., The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol, 3, 2012, 148.
3. [3] Zarrilli, R., Pournaras, S., Giannouli, M., Tsakris, A., Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 41 (2013), 11–19.
4. [4] Dijkshoorn, L., Nemec, A., Seifert, H., An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev 5 (2007), 939–951.
5. [5] Morey, P., Cano, V., Marti-Lliteras, P., Lopez-Gomez, A., Regueiro, V., Saus, C., et al. Evidence for a non-replicative intracellular stage of nontypable Haemophilus influenzae in epithelial cells. Microbiology 157 (2011), 234–250.
6. [6] Remuzgo-Martinez, S., Aranzamendi-Zaldunbide, M., Pilares-Ortega, L., Icardo, J.M., Acosta, F., Martinez-Martinez, L., et al. Interaction of macrophages with a cytotoxic Serratia liquefaciens human isolate. Microbes Infect 15 (2013), 480–490.
7. [7] Ramos-Vivas, J., Pilares-Ortega, L., Remuzgo-Martinez, S., Padilla, D., Gutierrez-Diaz, J.L., Navas-Mendez, J., Rhodococcus equi human clinical isolates enter and survive within human alveolar epithelial cells. Microbes Infect 13 (2011), 438–446.
8. [8] Nunley, D.R., Bauldoff, G.S., Mangino, J.E., Pope-Harman, A.L., Mortality associated with Acinetobacter baumannii infections experienced by lung transplant recipients. Lung 188 (2010), 381–385.
9. [9] Behnia, M., Logan, S.C., Fallen, L., Catalano, P., Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis. BMC Res Notes, 7, 2014, 232.
10. [10] Eijkelkamp, B.A., Stroeher, U.H., Hassan, K.A., Papadimitrious, M.S., Paulsen, I.T., Brown, M.H., Adherence and motility characteristics of clinical Acinetobacter baumannii isolates. FEMS Microbiol Lett 323 (2011), 44–51.
11. [11] Jacobs, A.C., Hood, I., Boyd, K.L., Olson, P.D., Morrison, J.M., Carson, S., et al. Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect Immun 78 (2010), 1952–1962.
12. [12] de Breij, A., Gaddy, J., van der Meer, J., Koning, R., Koster, A., van den Broek, P., et al. CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response. Res Microbiol 160 (2009), 213–218.
13. [13] Krzyminska, S., Frackowiak, H., Kaznowski, A., Acinetobacter calcoaceticus-baumannii complex strains induce caspase-dependent and caspase-independent death of human epithelial cells. Curr Microbiol 65 (2012), 319–329.
14. [14] Na, I.Y., Chung, E.S., Jung, C.Y., Kim, D.H., Shin, J., Kang, K., et al. Comparison of the virulence-associated phenotypes of five species of Acinetobacter baumannii complex. J Microbiol Biotechnol 26 (2016), 171–179.
15. [15] Booth, J.W., Telio, D., Liao, E.H., McCaw, S.E., Matsuo, T., Grinstein, S., et al. Phosphatidylinositol 3-kinases in carcinoembryonic antigen-related cellular adhesion molecule-mediated internalization of Neisseria gonorrhoeae. J Biol Chem 278 (2003), 14037–14045.
16. [16] Heesemann, J., Laufs, R., Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell culture. J Clin Microbiol 22 (1985), 168–175.
17. [17] Bist, P., Dikshit, N., Koh, T.H., Mortellaro, A., Tan, T.T., Sukumaran, B., The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection. Infec Immun 82 (2014), 1112–1122.